Small CDMO
Market Cap
₹29,243 ₹29,243 Cr.
P/E
0.00
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis turns live if CDMO order inflows recover sustainably and the large customer's destocking does not recur, alongside timely ex-US Sevoflurane approvals.- The bull path requires faster CDMO commercial conversion and ROW approvals, with utilization and mix driving operating leverage.
- The bear path is driven by renewed destocking or weak biotech funding, delayed approvals, and persistent pricing or consumer-healthcare pressure.

Financial

Business

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material